American Cannabis Company, Inc. Discusses Its 2021 Acquisition Strategy with The Stock Day Podcast

Phoenix, Arizona–(Newsfile Corp. – January 28, 2021) – The Stock Day Podcast welcomed American Cannabis Company, Inc. (OTCQB: AMMJ) (“the Company”), a company that offers end-to-end solutions to existing and aspiring participants in the cannabis and hemp industries. CEO of the Company, Terry Buffalo, joined Stock Day host Everett Jolly.

Jolly commented on the Company’s impressive growth over the last year, and asked about their background and current projects. “American Cannabis Company has been around since 2013,” shared Buffalo. “The company has built out over 2 million square feet of growth space, and along the way we have been looking to add additional products and services, which we have with SoHum Living Soils®,” he continued. “We’re currently looking to make these acquisitions and we’re happy to be able to diversify our income, and hopefully level our income, by adding these acquisitions to our portfolio.”

Jolly then asked about the Company’s recent announcement detailing a non-binding Letter of Intent (LOI) to purchase assets of Good Meds and BOSM Labs, a cannabis cultivation and extraction facility operating in a 60,000 sq. ft. building. “We have started the due diligence and the audit process is underway, and we’re looking to close this acquisition hopefully in the second quarter of this year,” said Buffalo. “It provides us the opportunity to expand up to 60,000 sq. ft. to help meet the growing medical and adult demand in the Colorado market.”

The conversation then turned to BOSM Labs, which produces live resin, live batter, budder, and shatter. “One of the big advantages of BOSM is that it is a hydrocarbon extraction lab. So, that will provide us the ability to add new products, SKUs, and meet the ever-growing demand here in the Colorado market.”

“What do you think will be some of the catalysts you will try to get done in the next two to three quarters?” asked Jolly. “The biggest thing is to get these two acquisitions that we have on the schedule for 2021, get them integrated into the company, and then start looking for 2022 opportunities,” said Buffalo.

Buffalo then elaborated on the Company’s consulting services division. “We’ve seen a big increase in calls and emails into the company. We have new clients now in all five states, and we are currently looking to add a few more in each one of those five states,” said Buffalo. “We’re looking for additional states to potentially come onboard before the end of the year, which will hopefully increase our consulting business for 2021.”

To close the interview, Buffalo shared that the Company will continue to be strategic in their acquisitions with a strong focus on building shareholder value. “We’re not just looking at top-line numbers, we’re looking to see how we can have profit,” said Buffalo. “That is our goal and I appreciate our shareholders being patient,” he added. “We’re working every day to bring value and provide a much cleaner type of product for the consumer than what is out there right now. Cleaner and greener is always the standard.”

To hear Terry Buffalo’s entire interview, follow the link to the podcast here: https://audioboom.com/posts/7784397-american-cannabis-company-inc-discusses-its-2021-acquisition-strategy-with-the-stock-day-podcast

Investors Hangout is a proud sponsor of “Stock Day,” and Stock Day Media encourages listeners to visit the company’s message board at https://investorshangout.com/

About American Cannabis Company, Inc.

American Cannabis Company, Inc. offers end-to-end solutions to existing and aspiring participants in the cannabis and hemp industries. We utilize our industry expertise to provide business planning and market assessment services, assist state licensing procurement, create business infrastructure and operational best practices. We are continuing to grow the Company by promoting our operational management services, and license the American Cannabis Company brand, as well as continuing to analyze acquisition opportunities worldwide. American Cannabis Company also developed and owns a portfolio of branded products including: SoHum Living Soils® – Winner of the High Times S.T.A.S.H Award for “Best Potting Mix”, The Cultivation Cube™ and the High-Density Cultivation System™. We also design and provide other industry specific custom product solutions.

For more information about American Cannabis Company, please visit:
www.theacclife.com
www.americancannabisconsulting.com
www.americancannabiscompanyinc.com
www.sohumsoils.com
www.americanhempservices.com

For more information on Good Meds, please visit:
https://www.goodmeds.com/

For more information on BOSM Labs, please visit:
https://www.goodmeds.com/bosm-labs/

Video Links:
https://americancannabisconsulting.com/resources/video/ (ACC Site)
https://www.youtube.com/watch?v=aENC4aeNZis (High Density Cultivation System)
https://www.youtube.com/watch?v=e9rNxFph_tQ&t (Cultivation Cube)
https://www.youtube.com/watch?v=XoIcopO2yE8&t (SoHum Living Soils®)

Forward Looking Statements

This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based drugs. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time to time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

Cannabis Remains an Illegal Schedule 1 Drug Under Federal Law

Cannabis and its derivatives are considered illegal “Schedule 1” drugs under the Controlled Substances Act (21 U.S.C. § 811). As such, Cannabis and its derivatives are viewed as being highly addictive and having no medical value. The United States Drug Enforcement Agency enforces the Controlled Substances Act, and persons violating it are subject to federal criminal prosecution. The criminal penalty structure in the Controlled Substances Act is determined based on the specific predicate violations, including but not limited to: simple possession, drug trafficking, attempt and conspiracy, distribution to minors, trafficking in drug paraphernalia, money laundering, racketeering, environmental damage from illegal manufacturing, continuing criminal enterprise, and smuggling. A first conviction under the Controlled Substances Act can generally result in possible fines from $250,000 to $50 million dollars, and incarceration for periods generally from five and up to forty years. For a second conviction, fines increase generally from $500,000 to $75 million dollars, and incarceration for periods generally from ten years to twenty years to life.

Contact:

[email protected]
303-974-4770

About The “Stock Day” Podcast

Founded in 2013, Stock Day is the fastest growing media outlet for Nano-Cap and Micro-Cap companies. It educates investors while simultaneously working with penny stock and OTC companies, providing transparency and clarification of under-valued, under-sold Micro-Cap stocks of the market. Stock Day provides companies with customized solutions to their news distribution in both national and international media outlets. The Stock Day Podcast is the number one radio show of its kind in America. Stock Day recently launched its Video Interview Studio located in Phoenix, Arizona.

SOURCE:

Stock Day Media
(602) 821-1102

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/73058

American Cannabis Company, Inc. Announces Execution of Non-Binding Letter of Intent for Strategic Acquisition of a 60,000-sq.-ft. Cannabis Cultivation and Extraction Operation in Denver, Colorado

DENVER, CO / NEWMEDIAWIRE / January 21, 2021 – American Cannabis Company, Inc. (OTCQB: AMMJ) (“ACC” or “Company”) is pleased to announce that it has successfully executed a non-binding letter of intent (LOI) with Andina Gold Corporation (OTCQB: AGOL) to purchase assets of its Good Meds and BOSM Labs operating division, a fully licensed cultivation and extraction operation in Colorado offering premium cannabis and cannabis extracts to the wholesale and retail medical and recreational markets. Assets are to include one cultivation operation and one hydrocarbon extraction laboratory and production center. All assets to be acquired will operate out of a 60,000-square-foot facility, centrally located in Denver, Colorado. Currently, only 50,000 square feet of space are being utilized, with 10,000 square feet of additional open space ready and available for the Company to use as it looks to scale up operations.

Since 2009, the Good Meds brand has cultivated and provided top-tier cannabis flower products to medical patients and recreational consumers in Colorado. BOSM Labs carries a strong reputation as a high-end manufacturer of well-known hydrocarbon-extracted cannabis products. Combined under one roof, these brands act as one of few long-standing and major contenders in the maturing Denver market.

Christopher Hansen, Chief Executive Officer of Andina Gold Corporation, commented: “We are pleased with the non-binding letter of intent with American Cannabis Company, and look forward to working with Terry Buffalo and his team to complete the transaction. The dedicated, consistently excellent work of Good Meds and BOSM Labs personnel has been the driver of their excellent reputation. We also appreciate the steady leadership through this transitional period provided by Amanda Price and John Haugh. We feel confident the impressive work of Good Meds and BOSM Labs will continue as we hand over the keys to American Cannabis Company.”

Terry Buffalo, Chief Executive Officer and Chief Financial Officer of American Cannabis Company, commented, “This is another strategic move for ACC. Officially having secured two non-binding LOIs to date, ACC will soon integrate three retail dispensaries and a total of 70,000 square feet of combined cultivation and extraction operations. The due diligence process for Good Meds and BOSM Labs has begun, and we anticipate this to close in Q2 of 2021. We analyzed many opportunities both here in Colorado as well as in other states, and we ultimately chose to focus on the Colorado market initially. This approach will allow us to improve existing operational processes, refine our workflow and deploy an operational management platform that we can use as we branch out to other regions of the country.”

About American Cannabis Company, Inc.

 American Cannabis Company, Inc. offers end-to-end solutions to existing and aspiring participants in the cannabis and hemp industries. We utilize our industry expertise to provide business planning and market assessment services, assist state licensing procurement, create business infrastructure and operational best practices. We are continuing to grow the company by promoting our operational management services and license the American Cannabis Company brand as well as continuing to analyze acquisition opportunities worldwide. American Cannabis Company also developed and owns a portfolio of branded products including: SoHum Living Soils® – Winner of the High Times S.T.A.S.H. Award for “Best Potting Mix,” The Cultivation Cube™ and the High-Density Cultivation System™. American Cannabis Company also designs and provides other industry-specific custom product solutions.

For more information about American Cannabis Company, please visit:

www.theacclife.com

www.americancannabisconsulting.com
www.americancannabiscompanyinc.com
www.sohumsoils.com

www.americanhempservices.com

Video Links:

https://americancannabisconsulting.com/resources/video/ (ACC Site)

https://www.youtube.com/watch?v=aENC4aeNZis (High Density Cultivation System)

https://www.youtube.com/watch?v=e9rNxFph_tQ&t (Cultivation Cube)

https://www.youtube.com/watch?v=XoIcopO2yE8&t (SoHum Living Soils®)

 

About Good Meds

Founded in 2009, Good Meds medical cannabis dispensaries in Englewood and Lakewood, Colorado offer affordable access to premier cannabis for registered Colorado medical cannabis patients. The company’s carefully curated genetics are grown using the highest quality ingredients, to address a full spectrum of medical ailments. Good Meds generates revenue through its retail sales as well as wholesale products sold to non-Good Meds retail outlets in the recreational market. Good Meds supports the growth of the cannabis industry and abides by responsible business practices. The Good Meds assets were acquired by Andina Gold Corp. in 2019. For more information on Good Meds, please visit: https://www.goodmeds.com/.

About BOSM Labs

Serving the Colorado market since 2017, BOSM Labs balances science and art to produce quality-first, boutique extracts sold at both medical and recreational cannabis outlets. BOSM’s single-source concentrates begin with an artisan cultivation team and end with pronounced flavors that truly capture the essence of the flower at harvest. For more information on BOSM Labs, please visit: https://www.goodmeds.com/bosm-labs/.

 

Contact:
[email protected]

303-974-4770

[email protected]

303-222-8092

 Forward-Looking Statements

This news release contains “forward-looking statements,” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”. These or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based drugs. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time to time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

Cannabis Remains an Illegal Schedule 1 Drug Under Federal Law

Cannabis and its derivatives are considered illegal “Schedule 1” drugs under the Controlled Substances Act (21 U.S.C. § 811). As such, Cannabis and its derivatives are viewed as being highly addictive and having no medical value. The United States Drug Enforcement Agency enforces the Controlled Substances Act, and persons violating it are subject to federal criminal prosecution. The criminal penalty structure in the Controlled Substances Act is determined based on the specific predicate violations, including but not limited to: simple possession, drug trafficking, attempt and conspiracy, distribution to minors, trafficking in drug paraphernalia, money laundering, racketeering, environmental damage from illegal manufacturing, continuing criminal enterprise, and smuggling. A first conviction under the Controlled Substances Act can generally result in possible fines from $250,000 to $50 million dollars, and incarceration for periods generally from five and up to forty years. For a second conviction, fines increase generally from $500,000 to $75 million dollars, and incarceration for periods generally from ten years to twenty years to life.

Terry Buffalo To Be Judge on the Investor Hot Seat Webinar

Denver, CO, January 19, 20210 – American Cannabis Company will be represented by our CEO, Terry Buffalo who will be an Investor Judge at the upcoming “Investor Hot Seat – Virtual Webinar”.

The first half of the webinar will focus on speakers and panels discussing strategies to mitigate risk investing in different investment opportunities.

This will be followed by a panel of investor judges who will listen to presentations from companies in the Investor Hot Seat that are raising capital from investment opportunities in agriculture, alternative funds, ESG, fintech, cannabis, health, hemp, media, medical, real estate, sustainability, and tech.

Please click here to register for the “Investor Hot Seat – Virtual Webinar”.

Investor Hot Seat Format

  • 11:00 AM – 1:00 PM PST – Speakers & Panels (25 Minutes)
  • 1:00 PM – 3:00 PM PST – Investor Pitch Competition
  • 3:00 PM – 4:00 PM Zoom Room Networking with Investors
  • Speakers & Panels (25 Minutes)
  • There are up to 8 companies that will be selected to pitch to a panel of investor judges and an audience of additional investors online.
  • Each company will receive 12 minutes to present and answer questions by judges.
  • Register Here

American Cannabis Company, Inc. Discusses Non-Binding LOI for The Acquisition of Naturaleaf with The Stock Day Podcast

Stock Day Podcast featuring Terry Buffalo

 

Phoenix, Arizona–(Newsfile Corp. – December 22, 2020) – The Stock Day Podcast welcomed American Cannabis Company, Inc. (OTCQB: AMMJ) (“the Company”), a company offering end-to-end solutions to existing and aspiring participants in the cannabis and hemp industries. CEO of the Company, Terry Buffalo, joined Stock Day host Everett Jolly.

Jolly began the interview by commenting on a recent press release by the Company detailing the execution of a non-binding letter of intent to purchase assets of Naturaleaf. “We’ve been looking for over a year to make an acquisition here in Colorado,” explained Buffalo. “Luckily, we came across Naturaleaf in Colorado Springs,” he continued. Buffalo then shared that the acquisition assets include three retail dispensaries, as well as a cultivation operation. “Naturaleaf is very compliant. Their financials are in order, and I can’t say enough about their team.”

“We have started doing our due diligence and the audit process is underway. We hope to have this closed by the first quarter of 2021,” shared Buffalo, adding that Naturaleaf is already established as a profitable company.

“What kind of impact will this have if it goes through?” asked Jolly. “It definitely will more than double our gross revenue from the previous year,” said Buffalo.

Jolly then asked about the potential of additional acquisitions in the near future. “We’re continuing to look in the Colorado market. We do have a couple of deals that we’re still negotiating,” explained Buffalo. “Our primary focus right now is in the Colorado market; we do see opportunity here.”

The conversation then turned to the discussion of new services launching in 2021. Buffalo elaborated on the Company’s cultivation management services and accounting services, which have received great feedback so far. “One of the things we’re really proud about is the new design of our Cultivation Cube™,” shared Buffalo. “One additional thing we’ve been able to do is offer [Cultivation Cube™] financing for qualified investors, not [directly] through American Cannabis Company, but through a third party.”

To close the interview, Buffalo thanked his shareholders for their continued patience and support. “We’ve always been very slow and methodical in our approach. We’re looking for opportunities that are going to create value for our shareholders,” said Buffalo, noting the potential of the acquisition of Naturaleaf. “We’re definitely looking for opportunities to bring to the company that will increase our shareholder value and provide us with positive cash flow.”

To hear Terry Buffalo’s entire interview, follow the link to the podcast here: https://audioboom.com/posts/7756353-american-cannabis-company-inc-discusses-non-binding-loi-for-the-acquisition-of-naturaleaf-with

Investors Hangout is a proud sponsor of “Stock Day,” and Stock Day Media encourages listeners to visit the company’s message board at https://investorshangout.com/

About American Cannabis Company, Inc.

American Cannabis Company, Inc. offers end-to-end solutions to existing and aspiring participants in the cannabis and hemp industries. We utilize our industry expertise to provide business planning and market assessment services, assist state licensing procurement, create business infrastructure and operational best practices. We are continuing to grow the Company by promoting our operational management services, and license the American Cannabis Company brand, as well as continuing to analyze acquisition opportunities worldwide. American Cannabis Company also developed and owns a portfolio of branded products including: SoHum Living Soils® – Winner of the High Times S.T.A.S.H Award for “Best Potting Mix”, The Cultivation Cube™ and the High-Density Cultivation System™. We also design and provide other industry specific custom product solutions.

For more information about American Cannabis Company, please visit:

www.theacclife.com

www.americancannabisconsulting.com

www.americancannabiscompanyinc.com

www.sohumsoils.com

www.americanhempservices.com

For more information on Naturaleaf, please visit:

www.thenaturaleaf.com

Video Links:

https://americancannabisconsulting.com/resources/video/ (ACC Site)

https://www.youtube.com/watch?v=aENC4aeNZis (High Density Cultivation System)

https://www.youtube.com/watch?v=e9rNxFph_tQ&t (Cultivation Cube)

https://www.youtube.com/watch?v=XoIcopO2yE8&t (SoHum Living Soils®)

Forward Looking Statements

This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based drugs. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time to time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

Cannabis Remains an Illegal Schedule 1 Drug Under Federal Law

Cannabis and its derivatives are considered illegal “Schedule 1” drugs under the Controlled Substances Act (21 U.S.C. § 811). As such, Cannabis and its derivatives are viewed as being highly addictive and having no medical value. The United States Drug Enforcement Agency enforces the Controlled Substances Act, and persons violating it are subject to federal criminal prosecution. The criminal penalty structure in the Controlled Substances Act is determined based on the specific predicate violations, including but not limited to: simple possession, drug trafficking, attempt and conspiracy, distribution to minors, trafficking in drug paraphernalia, money laundering, racketeering, environmental damage from illegal manufacturing, continuing criminal enterprise, and smuggling. A first conviction under the Controlled Substances Act can generally result in possible fines from $250,000 to $50 million dollars, and incarceration for periods generally from five and up to forty years. For a second conviction, fines increase generally from $500,000 to $75 million dollars, and incarceration for periods generally from ten years to twenty years to life.

Contact:
[email protected]

303-974-4770

About The “Stock Day” Podcast

Founded in 2013, Stock Day is the fastest growing media outlet for Nano-Cap and Micro-Cap companies. It educates investors while simultaneously working with penny stock and OTC companies, providing transparency and clarification of under-valued, under-sold Micro-Cap stocks of the market. Stock Day provides companies with customized solutions to their news distribution in both national and international media outlets. The Stock Day Podcast is the number one radio show of its kind in America. Stock Day recently launched its Video Interview Studio located in Phoenix, Arizona.

SOURCE:
Stock Day Media
(602) 821-1102

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/70812

American Cannabis Company, Inc. Announces Executed Non-Binding Letter of Intent (LOI) for Strategic Acquisition in Southern Colorado

DENVER, CO / NEWMEDIAWIRE / December 17, 2020 / American Cannabis Company, Inc. (OTCQB: AMMJ) (“ACC” or “Company”), a full-service business-to-business cannabis and hemp consulting solutions provider, is pleased to announce that it has successfully executed a non-binding letter of intent (LOI) to purchase assets of Naturaleaf, a long-standing licensed operator in the Colorado Springs medical cannabis market since 2009. Assets include three (3) retail dispensaries located throughout the city along and one (1) 10,000 square foot cultivation operation with non-volatile extraction capabilities.

After having recently received Marijuana Enforcement Division (MED) approval for a Suitability License, ACC is one of only few publicly traded companies authorized to acquire and operate various cannabis licenses throughout Colorado. This acquisition serves to aid in the Company’s overall expansion strategy to become a national cannabis operator.

Naturaleaf, a well-known brand frequently sought out by locals in the Colorado Springs area, has been providing medical patients with cannabis and cannabis-derived products for over ten (10) years. It’s staff and patient specialists maintain a very active presence in the local community, strive to find patients the right medicine for present or given conditions, and promote cannabis education to its patrons in a one-on-one retail concierge experience.

Scott Saunders, owner of Naturaleaf, commented, “I’m very pleased Naturaleaf has been chosen by American Cannabis Company for acquisition. My team, my wife, Lois and I have worked very hard and diligently since 2009 to create Naturaleaf as a genuine service to our patients, our employees and the community. Our strict compliance policies and dedication to high quality production and customer service through the years has positioned Naturaleaf firmly in the Colorado Springs market. I’m excited for our patients and employees. I see American Cannabis Company as an ideal candidate to take advantage of emerging opportunities in the cannabis space and to capitalize on what we’ve built.”

Terry Buffalo, Chief Executive Officer of American Cannabis Company commented, “We have spent much time and effort analyzing the Colorado market for the right opportunity to move into cannabis operations. As a publicly traded company, it has been difficult to locate acquisition opportunities where the seller’s financials are auditable under PCAOB stipulations and ASC-805 rules. After having vetted many deals in the Colorado market both in operations and in looking at financials, we determined that Naturaleaf was the best opportunity for us to enact the pivot into our new business model. We are now underway with the due diligence process and required audit, which we expect to close in Q1 of 2021. This first acquisition will be the catalyst that brings ACC into the fold as licensed cannabis operators, securing a foothold in Colorado as we continue to pursue additional acquisition opportunities nationally.”

About American Cannabis Company, Inc.

 American Cannabis Company, Inc. offers end-to-end solutions to existing and aspiring participants in the cannabis and hemp industries. We utilize our industry expertise to provide business planning and market assessment services, assist state licensing procurement, create business infrastructure and operational best practices. We are continuing to grow the Company by promoting our operational management services, and license the American Cannabis Company brand, as well as continuing to analyze acquisition opportunities worldwide. American Cannabis Company also developed and owns a portfolio of branded products including: SoHum Living Soils® – Winner of the High Times S.T.A.S.H Award for “Best Potting Mix”, The Cultivation Cube™ and the High-Density Cultivation System™. We also design and provide other industry specific custom product solutions.

 

For more information about American Cannabis Company, please visit:

www.theacclife.com

www.americancannabisconsulting.com
www.americancannabiscompanyinc.com
www.sohumsoils.com

www.americanhempservices.com

 

For more information on Naturaleaf, please visit:

www.thenaturaleaf.com

Video Links:

https://americancannabisconsulting.com/resources/video/ (ACC Site)

https://www.youtube.com/watch?v=aENC4aeNZis (High Density Cultivation System)

https://www.youtube.com/watch?v=e9rNxFph_tQ&t (Cultivation Cube)

https://www.youtube.com/watch?v=XoIcopO2yE8&t (SoHum Living Soils®)

 

Forward Looking Statements

This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based drugs. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time to time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

Cannabis Remains an Illegal Schedule 1 Drug Under Federal Law

Cannabis and its derivatives are considered illegal “Schedule 1” drugs under the Controlled Substances Act (21 U.S.C. § 811). As such, Cannabis and its derivatives are viewed as being highly addictive and having no medical value. The United States Drug Enforcement Agency enforces the Controlled Substances Act, and persons violating it are subject to federal criminal prosecution. The criminal penalty structure in the Controlled Substances Act is determined based on the specific predicate violations, including but not limited to: simple possession, drug trafficking, attempt and conspiracy, distribution to minors, trafficking in drug paraphernalia, money laundering, racketeering, environmental damage from illegal manufacturing, continuing criminal enterprise, and smuggling. A first conviction under the Controlled Substances Act can generally result in possible fines from $250,000 to $50 million dollars, and incarceration for periods generally from five and up to forty years. For a second conviction, fines increase generally from $500,000 to $75 million dollars, and incarceration for periods generally from ten years to twenty years to life.

Contact:
[email protected]

303-974-4770

American Cannabis Company Discusses Approval of Operator’s License and Suitability From The Colorado Marijuana Enforcement Division with The Stock Day Podcast

Phoenix, Arizona / Newsfile Corp. / November 18, 2020/ The Stock Day Podcast welcomed American Cannabis Company, Inc. (AMMJ) (“the Company”), a company that offers end-to-end solutions to existing and aspiring participants in the cannabis and hemp industries. CEO of the Company, Terry Buffalo, joined Stock Day host Everett Jolly.

Jolly began the interview by commenting on a recent press release detailing the Company’s operator’s license approval by Colorado’s Marijuana Enforcement Division (MED), as well as their approval for suitability. “Up until this time last year, in the state of Colorado a public company could not own a plant-touching business,” explained Buffalo, noting that this rule was changed in January of 2020. “So, we as a public company went through suitability where we are approved to actually own a plant-touching business in the state of Colorado,” he continued. “We’re very excited and we’re exploring multiple opportunities in this state.”

“The operator’s license is an interesting nuance because it allows us to operate a facility without actually owning the license,” said Buffalo. “It really helps us go after our new cultivation management that we’re currently rolling out,” he said. “We’re excited to have both of those because we’re looking for ongoing recurring revenue and that will help us accomplish our goals.”

Jolly then asked about the Company’s revenue projections moving forward. Buffalo shared that the COVID-19 pandemic significantly reduced their consulting revenues, however revenues from their products have increased to make up 66% of their sales.

“We’re getting close to 100 retail stores across the US, we have distribution in the UK now, and we are looking to get back into the Canadian market,” shared Buffalo. “As we acquire opportunities here in the Colorado market, we’ll be using and promoting our own brand for the grow, dispensary, and manufacturing operations we’re looking to acquire.”

“How will the elections affect your business moving forward?” asked Jolly. “After COVID hit, it really took away our front-end business applications,” explained Buffalo. “With these five states now coming on, we are seeing a lot more leads coming into our pipeline. So, hopefully we’ll be able to continue offering additional services in those markets, and look to expand the American Cannabis name in markets that are friendly to public companies.”

“Is there anything new in services or products for American Cannabis Company right now?” asked Jolly. Buffalo shared that the Company is starting to receive interest for their cultivation management services, and has also been developing a cannabis client accounting and bookkeeping division. “We found that a lot of local accountants that are doing the books for these ventures and growth facilities really don’t understand 280E,” explained Buffalo, adding that the accounting division will help solve this issue. “We have also done a lot of upgrades to our Cultivation Cube,” shared Buffalo. “In SoHum in general, we are continuing to work on additional products,” he added, noting that this process takes several months of R&D before new products can be released.

To close the interview, Buffalo shared that the Company will continue to grow primarily through acquisitions over the next two quarters. “It’s time for American Cannabis Company, now that we have the ability with the laws changing, to fulfill and really branch out our brand,” said Buffalo. “Going forward as we’re able to make these acquisitions, knowing what we know best, and being able to increase efficiencies, we’ll be able to bring some topline gross numbers but also have a profitable number,” said Buffalo. “We’re looking at being very methodical as we look at these acquisitions to make sure that it will be able to bring value to our shareholders.”

To hear Terry Buffalo’s entire interview, follow the link to the podcast here: https://audioboom.com/posts/7732786-american-cannabis-company-discusses-approval-of-operator-s-license-and-suitability-from-the-color

To see more products from AMMJ click video links below:

The Cultivation Cube: https://www.youtube.com/watch?v=e9rNxFph_tQ&t=63s

HDCS: https://www.youtube.com/watch?v=aENC4aeNZis

SoHum Soils: https://www.youtube.com/watch?v=XoIcopO2yE8

Investors Hangout is a proud sponsor of “Stock Day,” and Stock Day Media encourages listeners to visit the company’s message board at https://investorshangout.com/

About American Cannabis Company, Inc.

American Cannabis Company, Inc. offers end-to-end solutions to existing and aspiring participants in the cannabis and hemp industries. We utilize our industry expertise to provide business planning and market assessment services, assist state licensing procurement, create business infrastructure and operational best practices. We are continuing to grow the Company by promoting our operational management services, and license the American Cannabis Company brand, as well as continuing to analyze acquisition opportunities worldwide. American Cannabis Company also developed and owns a portfolio of branded products including: SoHum Living Soils® – Winner of the High Times S.T.A.S.H Award for “Best Potting Mix”, The Cultivation Cube™ and the High-Density Cultivation System™. We also design and provide other industry specific custom product solutions.

American Cannabis Company, Inc. Announces Approval of Operator’s License by Colorado’s Marijuana Enforcement Division (MED)

DENVER, CO / NEWMEDIAWIRE / November 12, 2020 / American Cannabis Company, Inc. (OTCQB: AMMJ) (“ACC” or “Company”), a full-service business-to-business cannabis and hemp consulting solutions provider, is pleased to announce its approval for an Operator’s License by Colorado’s Marijuana Enforcement Division (MED).

On November 10, 2020, Colorado’s Marijuana Enforcement Division (MED), approved the Company’s application for an Operator’s License, allowing it to now manage and operate both recreational and medical cannabis operations throughout Colorado. This recent approval is key in the Company’s plan to effectively roll out its management services to operators who seek to improve their overall business efficiencies. In addition to this approval for an Operator’s License, the Company recently received MED approval for a Suitability License, establishing the Denver-based company as one of the few publicly traded companies authorized to acquire and operate various cannabis licenses throughout Colorado.

Terry Buffalo, Chief Executive Officer of American Cannabis Company commented, “We are happy to now have the ability to deploy our operational management platform across the Colorado market as we seek to continually expand our service offerings. We provide our suite of management services to those who may need guidance in various areas of business related to cultivation, retail or extraction operations. In having secured both suitability and operators licenses within Colorado, we now have a multi-pronged approach in advancing our brand forward in this market. As we effectively work to implement our growth strategies, we will actively deploy our management platform while continuing to pivot our business model and advance brand expansion efforts by looking at multiple operational acquisition opportunities.”

About American Cannabis Company, Inc.

 American Cannabis Company, Inc. offers end-to-end solutions to existing and aspiring participants in the cannabis and hemp industries. We utilize our industry expertise to provide business planning and market assessment services, assist state licensing procurement, create business infrastructure and operational best practices. We are continuing to grow the Company by promoting our operational management services, and license the American Cannabis Company brand, as well as continuing to analyze acquisition opportunities worldwide. American Cannabis Company also developed and owns a portfolio of branded products including: SoHum Living Soils® – Winner of the High Times S.T.A.S.H Award for “Best Potting Mix”, The Cultivation Cube™ and the High-Density Cultivation System™. We also design and provide other industry specific custom product solutions.

 

For more information, please visit:

www.theacclife.com
www.americancannabisconsulting.com
www.americancannabiscompanyinc.com
www.sohumsoils.com
www.americanhempservices.com

Video Links:

https://americancannabisconsulting.com/resources/video/ (ACC Site)
https://www.youtube.com/watch?v=aENC4aeNZis (High Density Cultivation System)
https://www.youtube.com/watch?v=e9rNxFph_tQ&t (Cultivation Cube)
https://www.youtube.com/watch?v=XoIcopO2yE8&t (SoHum Living Soils®)

Forward Looking Statements

This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based drugs. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time to time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

 

Cannabis Remains an Illegal Schedule 1 Drug Under Federal Law

Cannabis and its derivatives are considered illegal “Schedule 1” drugs under the Controlled Substances Act (21 U.S.C. § 811). As such, Cannabis and its derivatives are viewed as being highly addictive and having no medical value. The United States Drug Enforcement Agency enforces the Controlled Substances Act, and persons violating it are subject to federal criminal prosecution. The criminal penalty structure in the Controlled Substances Act is determined based on the specific predicate violations, including but not limited to: simple possession, drug trafficking, attempt and conspiracy, distribution to minors, trafficking in drug paraphernalia, money laundering, racketeering, environmental damage from illegal manufacturing, continuing criminal enterprise, and smuggling. A first conviction under the Controlled Substances Act can generally result in possible fines from $250,000 to $50 million dollars, and incarceration for periods generally from five and up to forty years. For a second conviction, fines increase generally from $500,000 to $75 million dollars, and incarceration for periods generally from ten years to twenty years to life.


Contact:

[email protected]
303-974-4770

American Cannabis Company, Inc. Announces Approval for Suitability by Colorado’s Marijuana Enforcement Division (MED) and Provides Company Update

American Cannabis Company, Inc. Announces Approval for Suitability by Colorado’s Marijuana Enforcement Division (MED) and Provides Company Update

DENVER, CO / ACCESSWIRE / October 7, 2020 / American Cannabis Company, Inc. (OTCQB: AMMJ) (“ACC” or “Company”), a full-service business-to-business cannabis and hemp consulting solutions provider, is pleased to announce its approval for suitability by Colorado’s Marijuana Enforcement Division (MED) as well as providing an overall update on the Company.

Awarding of Colorado MED Suitability License

On September 18, 2020, Colorado’s Marijuana Enforcement Division (MED), approved the Company’s application for suitability, establishing the Denver-based company as one of the few publicly traded companies authorized to acquire and operate various cannabis licenses throughout Colorado, in both the recreational and medical markets. The approval is essential in ACC’s plans to effectively implement its growth strategies for company acquisitions and to expand into cannabis operations throughout the state.

The Company has been evaluating numerous turn-key Colorado opportunities in anticipation of potential acquisitions for 2020, including cultivation operations, product manufacturing operations and retail dispensaries. The Company is working diligently to align its available liquidity with the right Colorado acquisition opportunities. Terry Buffalo, Chief Executive Officer of American Cannabis Company commented, “We are excited to finally be able to pursue license ownership opportunities in our own backyard here in Colorado, which is especially important as we pivot from a full-service cannabis consulting firm to a national cannabis brand.”

Overall Company Update

The Company is also pleased to provide an overall update on its progress year-to-date. The following information describes the Company’s experience, current work and future plans as it positions itself as a reputable and established brand within the regulated markets.

Anticipating the need to adopt to the ever-changing landscape of the industry, the Company made several internal adjustments to maximize business efficiencies.  Mr. Buffalo commented, “The first part of this year was all about focusing on our long-term growth. We streamlined many of our processes, reconfigured roles internally, and in turn created significant cost savings, the effects of which we should see in Q4. These changes have been significant, and we hope to be able to further reduce base operational costs in the future.”

With longevity in mind, the Company continually looks for means by which it can reduce operational costs to improve processes. Mr. Buffalo commented further, “The Company continues to grow and evolve, and changing conditions have had an impact on how we plan for success in the years to come. Our decisions will position us to take maximal advantage of market opportunities as we move forward, and we are committed to drive improvements to our business along with the metrics that will contribute to overall success.”

Impact of COVID-19

The Company has experienced various changes in the volume of new business due to the impact of the COVID-19 global pandemic. Mr. Buffalo, commented: “There’s an old adage, ‘Don’t waste a crisis.’ The Company adapted our thinking of this pandemic to see it as an opportunity to rethink how we can conduct more business effectively and create a healthier company overall.

Sales of the Company’s proprietary all-natural potting soil, SoHum Living Soils®, have increased significantly. Chief Operations Officer, Tyler Schloesser, commented, “Many steps have been taken in the past several weeks to modify processes, ramp up production, and keep a proper amount of inventory on hand and ready to ship. Additionally, implementation of a new inventory tracking system has contributed in helping the team to further streamline efforts, boost efficiencies and increase forecasting capacities related to order fulfillment. We have taken the time to analyze components of our processes with the purpose of scaling up production of SoHum Living Soils® and we have worked closely with our network of vendors to address not just the current needs of the market during this pandemic, but we have also gained the ability to source ingredients and produce our proprietary just-add-water potting mix in larger capacities.”

Prior to the economic impact experienced globally due the COVID-19 pandemic, a dozen or more states were predicted to legalize cannabis in some form or fashion by means of legislature or ballot measure. Mr. Buffalo, commented, “2020 was set to be a big year for the cannabis industry in terms of growth, and then the markets experienced in impact of COVID-19. As of today, there are only five potential states with the opportunity for cannabis legalization measures to pass this year. Residents in New Jersey, South Dakota, Arizona, and Montana are set to vote for recreational cannabis in November, with South Dakota set to vote simultaneously on both medical and recreational. Mississippi also qualified a business-friendly cannabis initiative for the November ballot as well.”

The Company will continue to market to and analyze prospective consulting opportunities that come from these regions of the country, so that it can align with client groups who have a competitive edge to win licenses. We will also continue to provide our full suite of long-standing and proven consulting services to existing markets as the industry continues to mature. While this pandemic has slowed down the growth timelines of some in this industry, we feel as though we are strongly positioned as a reputable and established consulting brand to withstand the future economic effects brought on by COVID-19.

Company 2020 Highlights

  • Developed dispensary and cultivation conceptual designs for a Michigan client;
  • Submitted craft cultivation, infuser, and transportation license applications on behalf of four (4) clients in Illinois;
  • Finalized dispensary design for social equity client in Oakland, California;
  • Ongoing exploration of acquisitions in Colorado after HB 19-1090 passed;
  • Contracted to design, deploy, and manage cultivation facility in Michigan;
  • Contracted to complete business plan and financial pro-forma modeling for project in Arizona;
  • Contracted to complete pre-licensing work and hemp consulting for client project in Indiana;
  • Added expert witness services to the Company’s consulting platform;
  • Successfully awarded MED Suitability License to be able to qualify under Colorado HB19-1090 which allows the Company to make acquisitions of cannabis operations within the state;
  • Successfully submitted Licensed Operator applications to the Colorado MED which will allow for the Company to manage commercial and retail cannabis operations throughout the state;
  • Added ninety-three (93) SoHum Living Soils® retail/distribution outlets to date;
  • Establishing Advisory Board with purpose to gain further knowledge, understanding and advice from successful professionals related to a multitude of industries;
  • Added accounting and bookkeeping services to the Company’s consulting platform; and,
  • Began work on a 24,000 square foot cultivation project for a client in Michigan to provide construction support, deployment services, and full-scale operational management services

Acquisitions

The Company is continually evaluating various strategic acquisition opportunities for existing licenses across the country, as it seeks to both diversify and expand the overall brand footprint.

The Company raised capital through its equity line, and continues looking for additional capital to provide funding for its ongoing acquisition plans. Central to its growth plans, the Company is targeting markets providing easier means for publicly traded companies to own and operate licenses. As of today, the markets of most interest include Colorado, Massachusetts, Nevada, Michigan, and Arizona.

Operational Management Services

In 2019, the Company unveiled a more robust platform of facility on-site and remote operational management services to cannabis business operators seeking assistance with general oversight to improve underperforming assets. The Company has taken on a management contract in Michigan since rolling out this service, and currently the company is working to actively secure additional opportunities in other states. This platform is open to any existing operator throughout the country who is licensed in a regulated cannabis market and is interested in end-to-end facility management services.

SoHum Living Soils®

SoHum Living Soils® was created to combat complex cannabis cultivation strategies, both on a home and commercial scale. Originating from Southern Humboldt, California, this potting mix is a complete blend that optimizes a plants genetic potential. Revenues based on SoHum Living Soils® have increased 190% from Q2 of 2019 to Q2 2020. The Company has experienced exponential growth in product sales this year, and many steps have been taken internally to scale production in order to meet seemingly continuous demand. Much effort has been put forth in selecting and adding members to the sales team, upgrading inventory tracking solutions, and coordinating with vendors on production and forecasting.

Ellis Smith, Co-founder and Chief Development Officer of American Cannabis Company, Inc., commented, “The SoHum Living Soils® line of products has truly taken off this year. We are excited to see such explosive growth in this sector of our business and it is rewarding to receive consistent testimonials from growers who indicate that they experienced amazing results when using SoHum. This soil, designed to grow a cannabis plant from its early life all the way to harvest, also works perfectly for the hobbyist gardener who wishes to cultivate premiere fruits and vegetables. Having worked on perfecting the formula for many years, the team and I will continue to perform soil and crop analyses in effort to continually fine-tune and expand our soil product line in the future. As we continue to remain on the cutting edge of cannabis cultivation, new products are being developed and rigorously tested with hope that we will be expanding the overall SoHum product line very soon. I am very grateful to the sales team for their efforts and appreciate all the hard work that is put into the SoHum brand. Amazing teams produce and sell amazing soil, and I look forward to the continued growth of each as this product line continues to accelerate along with demand in this sector.”

Those looking to purchase SoHum Living Soils® can do so by contacting an official distributor or visiting the official website. The SoHum Living Soils® potting mix is also available for purchase on the Walmart, The Home Depot and Amazon online store platforms.

About American Cannabis Company, Inc.

American Cannabis Company, Inc. offers end-to-end solutions to existing and aspiring participants in the cannabis and hemp industries. We utilize our industry expertise to provide business planning and market assessment services, assist state licensing procurement, create business infrastructure and operational best practices. We are continuing to grow the Company by promoting our operational management services, and license the American Cannabis Company brand, as well as continuing to analyze acquisition opportunities worldwide. American Cannabis Company also developed and owns a portfolio of branded products including: SoHum Living Soils® – Winner of the High Times S.T.A.S.H Award for “Best Potting Mix”, The Cultivation Cube™ and the High-Density Cultivation System™. We also design and provide other industry specific custom product solutions.

For more information, please visit:

www.theacclife.com
www.americancannabisconsulting.com
www.americancannabiscompanyinc.com
www.sohumsoils.com
www.americanhempservices.com

Forward Looking Statements

This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based drugs. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time to time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

Cannabis Remains an Illegal Schedule 1 Drug Under Federal Law

Cannabis and its derivatives are considered illegal “Schedule 1” drugs under the Controlled Substances Act (21 U.S.C. § 811). As such, Cannabis and its derivatives are viewed as being highly addictive and having no medical value. The United States Drug Enforcement Agency enforces the Controlled Substances Act, and persons violating it are subject to federal criminal prosecution. The criminal penalty structure in the Controlled Substances Act is determined based on the specific predicate violations, including but not limited to: simple possession, drug trafficking, attempt and conspiracy, distribution to minors, trafficking in drug paraphernalia, money laundering, racketeering, environmental damage from illegal manufacturing, continuing criminal enterprise, and smuggling. A first conviction under the Controlled Substances Act can generally result in possible fines from $250,000 to $50 million dollars, and incarceration for periods generally from five and up to forty years. For a second conviction, fines increase generally from $500,000 to $75 million dollars, and incarceration for periods generally from ten years to twenty years to life.

Contact:
[email protected]
303-974-4770

American Cannabis Company, Inc. Discusses Its 2020 Strategy with The Stock Day Podcast

Newsfile Corp

Phoenix, Arizona–(Newsfile Corp. – February 27, 2020) – The Stock Day Podcast welcomed American Cannabis Company, Inc. (AMMJ) (“the Company”), a company that offers end-to-end solutions to existing and aspiring participants in the cannabis and hemp industries. CEO and Director of the Company, Terry Buffalo, joined Stock Day host Sharon Lee.

Lee began the interview by asking Buffalo about the Company’s background and current projects. “American Cannabis has been around for about seven years, and we are a seed-to-sale consulting company,” explained Buffalo. “We go into new markets helping clients with their application work and business plan,” he continued, adding that the Company will also assist with the build-out and deployment of their client’s facilities as well as operational management.

Lee then commented on the Company’s financials throughout 2019, and asked about the factors that contributed to their revenue increases. Buffalo noted that the Company was able to take on additional revenue by working with multiple clients in the emerging markets of both Missouri and Illinois. “In 2020, hopefully we will have 6 to 7 new markets that are coming onboard, which will contribute to our 2020 progress going forward,” said Buffalo.

The conversation then turned to a discussion about the contraction of cannabis stock prices and the opportunity it represents for the Company. “You have companies that are not doing enough due diligence,” explained Buffalo, noting that many companies in the cannabis industry are not keeping up to date with their financials. “They’re just running kind of free to make acquisitions for top-line numbers,” he added. “Now the market is changing; you have investors who actually want a return on their money,” said Buffalo. “We’re going to continue seeing it be very challenging in the capital markets for private and public companies to be able to raise capital going forward,” he continued.

“How do you see American Cannabis taking advantage of this?”, asked Lee. “We’ve been very strategic and methodical,” shared Buffalo. He explained that one of the Company’s Missouri clients, CannCare, is looking to diversify their holdings in other markets. “We’re vetting a couple of deals with them currently. We hope that we will have some of those deals inked in the next couple of weeks,” said Buffalo. He also explained the Company’s recent strategic S1 filing in 2019, stating that the Company will “…have the liquidity available to us when the opportunities do present themselves.”

Lee then asked about the Company’s all natural, fully amended potting mix, SoHum Living Soils® (“SoHum”). “With SoHum in general, it’s a very clean product,” said Buffalo, noting that consumers are becoming more and more concerned with what they are ingesting and how products are developed or grown. “The other thing about SoHum is that it enables you to lower your costs tremendously,” explained Buffalo. “This is basically a product that from start all the way through harvest you need to add nothing but water. So, it helps to eliminate human error and labor costs,” said Buffalo.

To close the interview, Buffalo expressed the Company’s excitement for their future projects. “We do have a very clean balance sheet; we have no debt on our books, which is a rarity for the cannabis space,” said Buffalo. “We’re going to be very methodical as we’re looking at these acquisitions that we’re trying to bring under our company umbrella,” he added. “Again, we’ll be trying to bring some additional cash flow and positive numbers, which will also bring shareholder value.”

To watch the entire interview with American Cannabis Company, follow the link to the video here: https://www.youtube.com/watch?v=8DcmIOYsrps&feature=youtu.be

Investors Hangout is a proud sponsor of “Stock Day,” and Stock Day Media encourages listeners to visit the company’s message board at https://investorshangout.com/

About American Cannabis Company, Inc.

American Cannabis Company, Inc. offers end-to-end solutions to existing and aspiring participants in the cannabis and hemp industries. We utilize our industry expertise to provide business planning and market assessment services, assist state licensing procurement, create business infrastructure and operational best practices. We are continuing to grow the Company by promoting our operational management services, and furthermore, the firm has become more involved with taking equity positions in client projects, licensing the American Cannabis Company brand, as well as continuing to analyze acquisition opportunities worldwide. American Cannabis Company also developed and owns a portfolio of branded products including: SoHum Living Soils® – Winner of the High Times S.T.A.S.H Award for “Best Potting Mix”, The Cultivation Cube™ and the High-Density Cultivation System™. We also design and provide other industry specific custom product solutions.

For more information, please visit:

www.theacclife.com
www.americancannabisconsulting.com
www.sohumsoils.com
www.americanhempservices.com

Forward-Looking Statements

This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based drugs. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time to time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

Cannabis Remains an Illegal Schedule 1 Drug Under Federal Law

Cannabis and its derivatives are considered illegal “Schedule 1” drugs under the Controlled Substances Act (21 U.S.C. § 811). As such, Cannabis and its derivatives are viewed as being highly addictive and having no medical value. The United States Drug Enforcement Agency enforces the Controlled Substances Act, and persons violating it are subject to federal criminal prosecution. The criminal penalty structure in the Controlled Substances Act is determined based on the specific predicate violations, including but not limited to: simple possession, drug trafficking, attempt and conspiracy, distribution to minors, trafficking in drug paraphernalia, money laundering, racketeering, environmental damage from illegal manufacturing, continuing criminal enterprise, and smuggling. A first conviction under the Controlled Substances Act can generally result in possible fines from $250,000 to $50 million dollars, and incarceration for periods generally from five and up to forty years. For a second conviction, fines increase generally from $500,000 to $75 million dollars, and incarceration for periods generally from ten years to twenty years to life.

Contact:

[email protected]
303-974-4770

About The “Stock Day” Podcast

Founded in 2013, Stock Day is the fastest growing media outlet for Nano-Cap and Micro-Cap companies. It educates investors while simultaneously working with penny stock and OTC companies, providing transparency and clarification of under-valued, under-sold Micro-Cap stocks of the market. Stock Day provides companies with customized solutions to their news distribution in both national and international media outlets. The Stock Day Podcast is the number one radio show of its kind in America. Stock Day recently launched its Video Interview Studio located in Phoenix, Arizona.

SOURCE:
Stock Day Media
602-441-3474

Disclaimer

Stock Day Media publishes general information about our featured companies, and a basis for conducting due diligence. The general information we publish is based upon sources we believe to be trustworthy. However, you should always conduct your own due diligence on any company when considering whether or not to make an investment. Claims of past performance are no guarantee of future performance. Apart from the general information we publish about our featured companies, we may sometimes provide our own opinions about the industries and markets our featured companies do business in. All of the opinions we may make are our own, and must not be considered to be complete, precise, accurate, or current investment advice, or construed or interpreted as research. Any investment decisions you may make concerning any of our featured companies are solely your own responsibility based on your own due diligence. Our publications about our featured companies are provided only as an informational aid, and as a starting point for doing additional independent research and due diligence. We also recommend, as a general rule, that before investing in any security you should consult with a professional financial planner or advisor, and you should conduct a complete and independent investigation before investing in any security after prudent consideration of all pertinent risks.

Our featured companies compensate us for our publication services. We only accept cash consideration in exchange for our publication, and do not accept any form of equity compensation, either from our company clients or company-related third parties. We do not buy, sell or hold any securities in the companies we feature.

17b Disclosure

Section 17(b) of the 1933 Securities and Exchange Act requires publishers who distribute information about publicly traded securities for compensation, to disclose who paid them, the amount, and the type of payment. In order to be in full compliance with the Securities Act of 1933, Section 17(b), we are disclosing that we entered into a contract with American Cannabis Company, Inc. wherein we agreed to publish a podcast about the Company. In exchange for our services, the Company compensated us with $1,800.00.

We are not a registered broker, dealer, analyst, or adviser. We hold no investment licenses and may not sell, offer to sell or offer to buy any security. Our publications about our featured companies are not a recommendation to buy or sell any security.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/52895

American Cannabis Company, Inc. Announces The Appointment of Mr. David M. Godfrey To The Position Of Chief Financial Officer

DENVER, CO / NEW MEDIA NEWS / January 9, 2020 / American Cannabis Company, Inc. (OTCQB: AMMJ) (“ACC”), a full-service business-to-business cannabis and hemp consulting solutions provider, is pleased to announce the promotion and appointment of David Michael Godfrey as its new Chief Financial Officer. Mr. Godfrey brings over 40 years of experience to the leadership team, and his career has primarily focused on multiple state and multiple unit large scale restaurant chains, retail apparel and healthcare centers. Notably, Mr. Godfrey has developed systematic financial reporting standards for multi-brand restaurants across the country. With ACC’s expansion efforts to become a nationally recognized cannabis brand, such experience and tenure will serve as support to a methodical approach in acquisitions and the pursuit of operator’s licenses.

Prior to his employment with ACC, Mr. Godfrey supervised the financials, reporting and infrastructure for a 130+ restaurants throughout the United States, Mexico, Dubai, Japan and Germany. Having worked in the healthcare industry as a Director of Corporate Financial Planning, he also helped to develop the financial reporting standards for a multi-specialist physician practice while at the same time effectively downsizing an overgrown multi-entity organization. This international experience coupled with Mr. Godfrey’s deep understanding of financial planning, strategic planning, development, and contract negotiations will furthermore support American Cannabis Company in its plan to grow steadily and sustain as a long-term, well-known brand name.

Terry Buffalo, American Cannabis Company’s Principal Executive Officer, commented: “ACC is proud to announce the appointment of David Godfrey from VP of Finance to CFO. David started with us in September as VP of Finance, and in this short time he has demonstrated his skills and abilities having already improved upon our internal accounting processes and implementing more robust inventory tracking solutions. In addition to his current roles and responsibilities, Mr. Godfrey will help to identify and vet potential acquisition opportunities. With his diverse background he will be a valuable resource as we execute our planned national expansion.”

David Godfrey, CFO for American Cannabis Company, stated: “This is a unique time in the cannabis industry where the pioneers have forged the beginnings of the industry, thus providing multiple opportunities for consolidation, mergers and acquisitions to bring efficiencies and productivity to multiple units in markets throughout the US and Canada. With IRS regulations still

in place such as 280E, these opportunities bring about unique management issues in reporting and managing on a day-to-day and month-to-month basis. Coming from a tight margin industry, I feel the opportunity is right for ACC to further expand its strategic planning to be a fully- integrated cannabis company from soil to oil.”

About American Cannabis Company, Inc.

American Cannabis Company, Inc. offers end-to-end solutions to existing and aspiring participants in the cannabis and hemp industries. We utilize our industry expertise to provide business planning and market assessment services, assist state licensing procurement, create business infrastructure and operational best practices. We are continuing to grow the Company by promoting our operational management services, and furthermore, the firm has become more involved with taking equity positions in client projects, licensing the American Cannabis Company brand, as well as continuing to analyze acquisition opportunities worldwide. American Cannabis Company also developed and owns a portfolio of branded products including: SoHum Living Soils® – Winner of the High Times S.T.A.S.H Award for “Best Potting Mix”, The Cultivation CubeTM and the High-Density Cultivation SystemTM. We also design and provide other industry specific custom product solutions.

For more information, please visit:

www.theacclife.com
www.americancannabisconsulting.com
www.americancannabiscompanyinc.com
www.sohumsoils.com
www.americanhempservices.com

Forward Looking Statements

This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based drugs. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time to time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

Cannabis Remains an Illegal Schedule 1 Drug Under Federal Law

Cannabis and its derivatives are considered illegal “Schedule 1” drugs under the Controlled Substances Act (21 U.S.C. § 811). As such, Cannabis and its derivatives are viewed as being highly addictive and having no medical value. The United States Drug Enforcement Agency enforces the Controlled Substances Act, and persons violating it are subject to federal criminal prosecution. The criminal penalty structure in the Controlled Substances Act is determined based on the specific predicate violations, including but not limited to: simple possession, drug trafficking, attempt and conspiracy, distribution to minors, trafficking in drug paraphernalia, money laundering, racketeering, environmental damage from illegal manufacturing, continuing criminal enterprise, and smuggling. A first conviction under the Controlled Substances Act can generally result in possible fines from $250,000 to $50 million dollars, and incarceration for periods generally from five and up to forty years. For a second conviction, fines increase generally from $500,000 to $75 million dollars, and incarceration for periods generally from ten years to twenty years to life.

Contact:
[email protected]
(303) 974-4770